Shares of Lam Research Corporation (NASDAQ:LRCX - Get Free Report) have been given a consensus rating of "Moderate Buy" by the thirty-four ratings firms that are currently covering the firm, Marketbeat Ratings reports. Eight analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $285.9419.
LRCX has been the subject of a number of research reports. Needham & Company LLC reiterated a "buy" rating and set a $300.00 target price on shares of Lam Research in a research report on Thursday, April 23rd. Erste Group Bank cut shares of Lam Research from a "buy" rating to a "hold" rating in a research note on Thursday, April 2nd. Weiss Ratings raised shares of Lam Research from a "buy (b-)" rating to a "buy (b)" rating in a report on Friday, April 24th. Rothschild & Co Redburn lifted their price objective on shares of Lam Research from $225.00 to $265.00 and gave the company a "buy" rating in a research note on Friday, February 6th. Finally, BNP Paribas Exane boosted their target price on shares of Lam Research from $250.00 to $260.00 and gave the company a "neutral" rating in a report on Thursday, April 23rd.
View Our Latest Stock Report on LRCX
Insider Buying and Selling
In related news, Director Eric Brandt sold 35,000 shares of the stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the sale, the director owned 253,705 shares of the company's stock, valued at approximately $57,235,848. This represents a 12.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Douglas R. Bettinger sold 50,057 shares of the stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the completion of the sale, the chief financial officer directly owned 1,081,705 shares in the company, valued at approximately $242,334,371.15. The trade was a 4.42% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 155,066 shares of company stock valued at $35,849,242 in the last ninety days. 0.31% of the stock is owned by company insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in the company. Noesis Capital Mangement Corp raised its position in shares of Lam Research by 25.5% in the first quarter. Noesis Capital Mangement Corp now owns 24,007 shares of the semiconductor company's stock worth $5,129,000 after buying an additional 4,884 shares in the last quarter. Wealthfront Advisers LLC boosted its stake in Lam Research by 23.0% during the first quarter. Wealthfront Advisers LLC now owns 186,183 shares of the semiconductor company's stock valued at $39,780,000 after buying an additional 34,811 shares during the period. Navigation Group LLC purchased a new position in Lam Research during the first quarter worth about $1,384,000. Twin Capital Management Inc. increased its stake in Lam Research by 102.5% in the 1st quarter. Twin Capital Management Inc. now owns 16,606 shares of the semiconductor company's stock worth $3,548,000 after acquiring an additional 8,407 shares during the last quarter. Finally, Three Seasons Wealth LLC raised its holdings in shares of Lam Research by 12.4% in the 1st quarter. Three Seasons Wealth LLC now owns 23,704 shares of the semiconductor company's stock valued at $5,070,000 after acquiring an additional 2,608 shares in the last quarter. 84.61% of the stock is currently owned by hedge funds and other institutional investors.
Key Headlines Impacting Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Earnings beat + bullish near‑term guide — Lam reported a March‑quarter revenue and EPS beat and gave an upbeat June‑quarter outlook, which the market interpreted as accelerating wafer‑fab demand and margin expansion. Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand
- Positive Sentiment: TAM and secular demand lift the investment case — Analysts and commentators raised WFE and hyperscaler‑capex forecasts (Lam’s environment looks larger), reinforcing growth expectations and the claim that AI-driven device complexity benefits Lam’s etch/deposition exposure. Lam Research: $140B WFE, $725B In Hyperscaler Capex, And Still Raising -- BUY
- Positive Sentiment: Analyst target upgrades and bullish notes — Multiple firms have raised price targets and reiterated Outperform/Buy calls after the quarter, supporting momentum and upside thesis. Lam Research (LRCX) Surges to Record Highs: Analyzing the 252% Rally
- Positive Sentiment: Technical breakout / IBD recognition — The stock cleared an IBD buy point after the strong report, drawing momentum and retail/institutional interest. Lam Research, IBD Stock Of The Day, Clears Buy Point On Chip-Gear Investments
- Neutral Sentiment: Insider sale disclosed — An SVP sold ~18k shares under a pre‑arranged Rule 10b5‑1 plan; routine disclosure but worth noting for timing/context. Insider Selling: Lam Research NASDAQ: LRCX SVP Sells 18,170 Shares of Stock
- Neutral Sentiment: Valuation and “froth” commentary — Some analysis flags stretched multiples and consolidation risk after the run; elevated P/E requires investors to weigh growth vs. premium valuation. Lam Research Is Approaching Frothy Levels
- Negative Sentiment: Insider and institutional selling activity — Reports show multiple executive sales and notable institutional repositioning in recent quarters; while some are pre‑planned or rebalancing, sustained selling can temper sentiment if it continues. Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand
Lam Research Price Performance
Lam Research stock opened at $275.80 on Wednesday. The business's 50 day simple moving average is $236.99 and its 200 day simple moving average is $202.86. Lam Research has a 12 month low of $72.59 and a 12 month high of $280.00. The company has a market cap of $344.91 billion, a price-to-earnings ratio of 52.04, a PEG ratio of 2.14 and a beta of 1.81. The company has a current ratio of 2.54, a quick ratio of 1.77 and a debt-to-equity ratio of 0.35.
Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 EPS for the quarter, beating analysts' consensus estimates of $1.36 by $0.11. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.The firm had revenue of $5.84 billion for the quarter, compared to analysts' expectations of $5.70 billion. During the same quarter in the prior year, the firm earned $1.04 EPS. The business's revenue for the quarter was up 23.8% compared to the same quarter last year. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. Sell-side analysts forecast that Lam Research will post 5.68 EPS for the current year.
Lam Research Company Profile
(
Get Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
SpaceX has quietly filed to go public later this year. Ahead of what's expected to be the largest IPO of all time, there are seven space stocks that you can buy today that are positioned to benefit from accelerating space commercialization in 2026.
These seven companies are shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.